Xience

Original Contribution

Alex Plus Versus Xience Drug-Eluting Stents for Percutaneous Coronary Intervention in Routine Clinical Practice: A Propensity Score-Matched Analysis

04/01/2022

Nicola Corcione, MD^1,2; Paolo Ferraro, MD^1,2; Alberto Morello, MD^1,2; Michele Cimmino, MD^1,2; Michele Albanese^1,2; Martino Pepe, MD, PhD³; Palma Luisa Nestola, MD^1,2; Salvatore Giordano, MD⁴; Giuseppe Biondi-Zoccai, MD, MStat^5,6; Arturo Giordano, MD, PhD^1,2

Nicola Corcione, MD1,2; Paolo Ferrar...

The next iteration of drug-eluting stents (DESs) for percutaneous coronary intervention (PCI) has focused on bioresorbable polymers and thin struts. The Alex Plus DES is a new-generation sirolimus-eluting device with 70 µm cobalt chromium...

The next iteration of...

04/01/2022

Journal of Invasive Cardiology